Princeton University Press, Date: 2004-09-07. Hardcover. Used: Good. 2004. Princeton University Press ISBN 0691121133 9780691121130 [US]

ISBN10: 0691121133, ISBN13: 9780691121130, [publisher: Princeton University Press] Hardcover New Book. Shipped from UK. Established seller since 2000.
[Fairford, GLOS, United Kingdom] [Publication Year: 2004]

Princeton University Press 10/15/2004 12: 00: 00 AM Hardcover New Book. Shipped from UK in 4 to 14 days. Established seller since 2000. Please note we cannot offer an expedited shipping service from the UK.

Hardback. New. Millions of people in the third world die from diseases that are rare in the first world. Vaccines offer hope for controlling these diseases and could improve health in poor countries. But developers have little incentive to undertake the costly research to develop vaccines. This book details how these legally binding commitments would work. ISBN 0691121133 9780691121130 [GB]

Princeton University Press 10/15/2004 12: 00: 00 AM Hardcover PLEASE NOTE, WE DO NOT SHIP TO DENMARK. New Book. Shipped from UK in 4 to 14 days. Established seller since 2000. Please note we cannot offer an expedited shipping service from the UK.

ISBN10: 0691121133, ISBN13: 9780691121130, [publisher: Princeton University Press] Hardcover nach der Bestellung gedruckt Neuware - Printed after ordering - From Nobel Prize-winning economist Michael Kremer and fellow leading development economist Rachel Glennerster, an innovative solution for providing vaccines in poor countriesMillions of people in the third world die from diseases that are rare in the first world-diseases like malaria, tuberculosis, and schistosomiasis. AIDS, which is now usually treated in rich countries, still ravages the world's poor. Vaccines offer the best hope for controlling these diseases and could dramatically improve health in poor countries. But developers have little incentive to undertake the costly and risky research needed to develop vaccines. This is partly because the potential consumers are poor, but also because governments drive down prices.In Strong Medicine, Michael Kremer and Rachel Glennerster offer an innovative yet simple solution to this worldwide problem: 'Pull' programs to stimulate research. Here's how such programs would work. Funding agencies would commit to purchase viable vaccines if and when they were developed. This would create the incentives for vaccine developers to produce usable products for these neglected diseases. Private firms, rather than funding agencies, would pick which research strategies to pursue. After purchasing the vaccine, funders could distribute it at little or no cost ...
Show/Hide image

Princeton University Press, Date: 2004-09-27. Hardcover. New. New. In shrink wrap. Looks like an interesting title! 2004. Princeton University Press ISBN 0691121133 9780691121130 [US]